another company I hold, was required to resubmit an NDA because their instruction manual wasn’t up to scratch. That is the only thing they had left to tick off… FDA forced them to wait several months just for that. so this new data was always going to need another resubmission.
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-236
-
- There are more pages in this discussion • 861 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
90.5¢ |
Change
0.020(2.26%) |
Mkt cap ! $1.033B | |||
| Open | High | Low | Value | Volume |
| 88.5¢ | 95.0¢ | 88.0¢ | $5.610M | 6.115M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 12 | 317774 | 90.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 91.5¢ | 23500 | 2 |
View Market Depth
| Last trade - 16.10pm 06/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |